Overview
- 19 inspections across 18 sites are on record.
- 60 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-05-19.
At a glance
Inspections
19
Sites
18
Observations
60
Career since
Apr 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cilag AG | 19 May 2017 | Medical Devices & Rad Health | View 483 → |
| Novartis Pharma Stein AG | 9 May 2017 | Human Drugs | View 483 → |
| Partner Therapeutics, Inc. | 26 Aug 2016 | Human Drugs | On file |
| Genentech, Inc. | 15 Apr 2016 | Human Drugs | View 483 → |
| Erregierre SpA | 12 Feb 2016 | Human Drugs |
Sites inspected
Cilag AGSchaffhausen, Switzerland1 insp.
Novartis Pharma Stein AGStein Ag, Switzerland1 insp.
Partner Therapeutics, Inc.Lynnwood, United States1 insp.
Genentech, Inc.Hillsboro, United States1 insp.
Erregierre SpASan Paolo d'Argon, Italy1 insp.
Co-investigators
Investigators who share inspections with this person.
Carla J Lundi5 shared
Sharon K Thoma3 shared
Rachel C Harrington3 shared
Ademola O Daramola2 shared
Gerard P De Leon2 shared
Marijo B Kambere2 shared
Lynda L Perry2 shared
Chad N Thompson2 shared
Farhana Khan2 shared
Kristopher J Stanya1 shared
Full investigator report
Get the verbatim findings behind Don H Bark's 60 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site